Log In
BCIQ
Print this Print this
 

RBX7455

  Manage Alerts
Collapse Summary General Information
Company Rebiotix Inc.
DescriptionOral broad-spectrum microbiota restoration therapy
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationClostridium
Indication DetailsTreat recurrent Clostridium difficile infection (CDI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today